Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
52,368,071
-
Share change
-
+3,655,541
-
Total reported value
-
$312,921,001
-
Put/Call ratio
-
39%
-
Price per share
-
$5.98
-
Number of holders
-
70
-
Value change
-
+$27,258,116
-
Number of buys
-
39
-
Number of sells
-
30
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2021
As of 31 Mar 2021 Aptose Biosciences Inc. - Common Shares had 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,368,071 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, DRW Securities, LLC, Nantahala Capital Management, LLC, Cormorant Asset Management, LP, First Light Asset Management, LLC, PICTET ASSET MANAGEMENT LTD, EVENTIDE ASSET MANAGEMENT, LLC, Woodline Partners LP, Polar Capital Holdings Plc, and VR Adviser, LLC.
This table shows 71 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.